Glibenclamide
Drug Details
- Description
- Glibenclamide is an oral hypoglycemic agent used to treat type 2 diabetes mellitus. It belongs to the class of sulfonylureas and works by stimulating the release of insulin from pancreatic beta cells, thereby lowering blood glucose levels.
- Alternative Names
- Glibenclamide is also known as Glyburide.
- Key Genes
- Key genes associated with Glibenclamide response include ABCC8, KCNJ11, and TCF7L2.
- Drug Use
- Glibenclamide is used to manage type 2 diabetes by increasing insulin production from the pancreas.
- Genetic Factors Influencing Response
-
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Purchase Membership to Access Your Individual Drug Response Report